IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHRISTOPHER J SWANSON

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1023016847
CMS profile
904494
Location
RIVERSIDE, CA

General Payments · PY2018–2024

$249,957.36

  • Reported across 136 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$76,972.19

41 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Internal Medicine CA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $76,575.00 35
Travel and Lodging $397.19 6

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $76,972.19 41

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $25.00 1
PY2019 $26.98 2
PY2020 $591.45 7
PY2021 $40,829.86 19
PY2022 $74,790.71 34
PY2023 $56,721.17 32
PY2024 $76,972.19 41

Payment records · PY2024 (41)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137684522 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137684524 CMS
Takeda Pharmaceuticals U.S.A., Inc. $675.00 01/26/2024 Consulting Fee Undisputed 01/23/2026 1137684526 CMS
Takeda Pharmaceuticals U.S.A., Inc. $675.00 01/26/2024 Consulting Fee Undisputed 01/23/2026 1137684528 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,025.00 02/05/2024 Consulting Fee Undisputed 01/23/2026 1137684530 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137684532 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137684534 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137684536 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137684538 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137684540 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137684542 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137684544 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137684546 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137684548 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137684550 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137684552 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137684554 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137684556 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137684558 CMS
Takeda Pharmaceuticals U.S.A., Inc. $675.00 09/09/2024 Consulting Fee Undisputed 01/23/2026 1137684560 CMS
Takeda Pharmaceuticals U.S.A., Inc. $48.24 09/09/2024 Travel and Lodging Undisputed 01/23/2026 1137684562 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137684564 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137684566 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137684568 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137684570 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,800.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137684572 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137684574 CMS
Takeda Pharmaceuticals U.S.A., Inc. $675.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137684576 CMS
Takeda Pharmaceuticals U.S.A., Inc. $49.85 11/13/2024 Travel and Lodging Undisputed 01/23/2026 1137684578 CMS
Takeda Pharmaceuticals U.S.A., Inc. $700.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137684580 CMS
Takeda Pharmaceuticals U.S.A., Inc. $49.85 11/13/2024 Travel and Lodging Undisputed 01/23/2026 1137684582 CMS
Takeda Pharmaceuticals U.S.A., Inc. $675.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137684584 CMS
Takeda Pharmaceuticals U.S.A., Inc. $49.85 11/13/2024 Travel and Lodging Undisputed 01/23/2026 1137684586 CMS
Takeda Pharmaceuticals U.S.A., Inc. $675.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137684588 CMS
Takeda Pharmaceuticals U.S.A., Inc. $49.85 11/13/2024 Travel and Lodging Undisputed 01/23/2026 1137684590 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,100.00 12/04/2024 Consulting Fee Undisputed 01/23/2026 1137684592 CMS
Takeda Pharmaceuticals U.S.A., Inc. $149.55 12/04/2024 Travel and Lodging Undisputed 01/23/2026 1137684594 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,800.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137684596 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137684598 CMS
Takeda Pharmaceuticals U.S.A., Inc. $675.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137684600 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,025.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137684602 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.